Skip to content

Study on the regulating effect of Ginkgo biloba Extract ( GBE50) Dispersible Tablets on blood lipids in people with cardiovascular and cerebrovascular diseases in the real world

Study on the regulating effect of Ginkgo biloba Extract ( GBE50) Dispersible Tablets on blood lipids in people with cardiovascular and cerebrovascular diseases in the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006367
Enrollment
Unknown
Registered
2022-07-20
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular and cerebrovascular diseases

Interventions

case series:Nil

Sponsors

Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) The age is over 18 years old. The gender is not limited. (2) Subjects with cardiovascular and cerebrovascular diseases who have been treated in the hospital before June 2022, meet the diagnostic criteria for cardiovascular and cerebrovascular diseases (including cerebral infarction, coronary heart disease, and complications such as hypertension, diabetes, dyslipidemia, cardiac insufficiency, etc.); (3) The subjects had at least baseline and over six months blood lipids, blood routine, liver and kidney function test records.

Exclusion criteria

Exclusion criteria: (1) Subjects with a history of acute or chronic infection, or combined with severe immune system disease or blood system disease; (2) Subjects with severe cardiac insufficiency; (3) Subjects with severe liver and kidney complications or other serious primary diseases; (4) Subjects with a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Changes in low-density lipoprotein cholesterol LDL-C (mmol/L);

Secondary

MeasureTime frame
Changes in High density liptein cholesterol;Changes in triglycercide;Changes in total cholesterol;

Countries

China

Contacts

Public ContactHongsheng Tan

Shanghai Jiaotong University School of Medicine

tanhs@shsmu.edu.cn021-63846590-776752

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026